Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

被引：0
|
作者：
Hyungwoo Cho
Min-Hee Ryu
Kyu-pyo Kim
Baek-Yeol Ryoo
Sook Ryun Park
Bum Soo Kim
In-Seob Lee
Hee-Sung Kim
Moon-Won Yoo
Jeong Hwan Yook
Seong Tae Oh
Byung Sik Kim
Yoon-Koo Kang
机构：
[1] University of Ulsan College of Medicine,Department of Internal Medicine, Asan Medical Center
[2] University of Ulsan College of Medicine,Department of Oncology, Asan Medical Center
[3] University of Ulsan College of Medicine,Department of Surgery, Asan Medical Center
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Gastric cancer; Chemotherapy; Peritoneal metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：970 / 977
页数：7
相关论文
共 50 条
  • [1] Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
    Cho, Hyungwoo
    Ryu, Min-Hee
    Kim, Kyu-pyo
    Ryoo, Baek-Yeol
    Park, Sook Ryun
    Kim, Bum Soo
    Lee, In-Seob
    Kim, Hee-Sung
    Yoo, Moon-Won
    Yook, Jeong Hwan
    Oh, Seong Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    GASTRIC CANCER, 2017, 20 (06) : 970 - 977
  • [2] Phase I/II study of a combination of capecitabine, cisplatin, and intraperitonealdocetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis
    Cho, Hyungwoo
    Ryu, Min-Hee
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Park, Sook Ryun
    Kim, Kyu-Pyo
    Kim, Beom Su
    Yoo, Moon-Won
    Yook, Jeong Hwan
    Kim, Byung Sik
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP plus IP DOC trial.
    Fukushima, Ryoji
    Ishigami, Hironori
    Miwa, Hiroto
    Imano, Motohiro
    Kobayashi, Daisuke
    Tsuji, Yasushi
    Hidemura, Akio
    Kusumoto, Tetsuya
    Omori, Takeshi
    Yabusaki, Hiroshi
    Ohashi, Norifumi
    Ota, Mitsuhiko
    Yamaguchi, Hironori
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Park, YH
    Ryoo, BY
    Choi, SJ
    Kim, HT
    BRITISH JOURNAL OF CANCER, 2004, 90 (07) : 1329 - 1333
  • [5] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Y H Park
    B-Y Ryoo
    S-J Choi
    H-T Kim
    British Journal of Cancer, 2004, 90 : 1329 - 1333
  • [6] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [7] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [8] Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)
    Vatandoust, Sina
    Bright, Tim
    Roy, Amitesh Chandra
    Abbas, Muhammad Nazim
    Watson, David Ian
    Gan, Susan
    Bull, Jeff
    Sorich, Michael
    Scott-Hoy, Alex
    Luu, Lee-Jen
    Karapetis, Christos Stelios
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (04) : 404 - 409
  • [9] Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study
    Soh Saitoh
    Yuh Sakata
    Gastric Cancer, 2002, 5 (Suppl 1) : 23 - 26
  • [10] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
12345